Search the Newsreel

Morgan Stanley Maintains VERSIGENT PLC(VGNT.US) With Buy Rating, Raises Target Price to $58

Morgan Stanley has reiterated its "Buy" rating on VERSIGENT PLC (VGNT.US) and increased its target price for the company's shares to $58. This indicates a continued positive outlook from the investment bank regarding VERSIGENT's future performance.

Versigent PLC Stock 12‑Month Price Target Raised to $55.9, Implies 22% Upside

Versigent PLC (VGNT) has seen its average 12-month price target increase to $55.9 from $55.2, with individual forecasts ranging from $52 to $60. This new target suggests a 22% potential upside based on the Aug. 4 closing price. The stock maintains a "Buy" consensus …

Persimmon Plc 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:PSMMY) 2026-08-06

Recursion Pharmaceuticals (RXRX) Stock Looks Weak On Returns While Trading Above Fair Value

Recursion Pharmaceuticals (RXRX) stock has seen a significant decline over the past five years and is currently trading above its fair value based on various valuation checks. The company's P/S ratio of 30.7x is well above the biotech industry average, indicating it is expensive …

Persimmon improves completion guidance despite ‘challenging’ housing market

Housebuilder Persimmon has said it expects to deliver home completions at the "upper end" of targets, despite a challenging property market. Boss Dean Finch said that "affordability constraints and build cost pressures" are continuing to drag on the industry. However, the company said profits …

Versigent Ord Shs When Issued (VGNT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Rogers Sugar Inc. 2026 Q3 - Results - Earnings Call Presentation (TSX:RSI:CA) 2026-08-06

Persimmon (LON:PSN) Posts Earnings Results

Rush Street Interactive (RSI) CEO sells stock via 10b5-1 trading plan

Richard Todd Schwartz, CEO of Rush Street Interactive (RSI), sold 158,334 shares of Class A Common Stock through a 10b5-1 trading plan. The shares were sold in three transactions at weighted average prices ranging from $28.0219 to $28.0257 per share after converting Class A …

Rush Street Interactive (NYSE: RSI) COO sells 20,000 shares under 10b5-1 plan

Rush Street Interactive's COO, Mattias Stetz, sold 20,000 shares of Class A common stock on August 3, 2026, under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $28.0278, with individual trades ranging from $26.53 to $28.77. Following …

Diversified Energy Sells $147M of Assets, Plans Oklahoma Drilling

Persistent Systems holds non-deal roadshow with six mutual funds

Recursion Pharmaceuticals (RXRX) Is Up 11.4% After Mixed Q2 Results And Genentech Milestone Update

Recursion Pharmaceuticals, Inc. reported its Q2 2026 results, with revenue falling to US$7.67 million from US$19.22 million a year earlier, while its net loss narrowed to US$131.01 million and loss per share improved to US$0.25. Alongside these figures, the company highlighted progress on its …

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down Following Weak Earnings

Clearsign Technologies Corp (CLIR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Clearsign Technologies Corp (CLIR) has an earnings forecast score of 8.00, ranking 37 out of 181 in its industry. Analysts have set an average price target of $2.00, with a consensus "Buy" rating based on one analyst's assessment. The company's expected revenue for the …

Informe de resultados: Recursion no alcanza previsiones de ingresos en el Q2 2026 y sus acciones caen antes de la apertura del mercado

ClearSign to Issue June-Quarter Financial Results Aug. 19

ClearSign Technologies Corporation (NASDAQ: CLIR) announced it will host a conference call on Wednesday, August 19, 2026, at 5:00 PM ET to discuss its second-quarter 2026 financial and operating results. The company plans to file its Form 10-Q and issue a press release summarizing …

ClearSign Technologies Corporation Announces Second Quarter 2026 Conference Call

ClearSign Technologies Corporation (NASDAQ:CLIR) announced it will host a conference call on Wednesday, August 19th, 2026, at 5:00 PM ET to discuss its second-quarter financial and operating results for the period ending June 30, 2026. The company will file its quarterly report on form …

RECURSION PHARMACEUTICALS, INC. Q2 Loss Decreases

(RTTNews) - RECURSION PHARMACEUTICALS, INC. (RXRX) released Loss for second quarter of -$131.005 million The company's earnings came in at -$131.005 million, or -$0.25 per share. This compares with -$171.897 million, or -$0.41 per share, last year. The company's revenue for the period fell …

Recursion Pharmaceuticals (RXRX) Stock Still Looks Expensive Following August 5 Results Update

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Recursion Pharmaceuticals stock has had a difficult run over the past several years, and the current valuation checks lean toward the shares looking …

Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Misses Revenue Estimates

Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.41 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …

Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

Recursion (Nasdaq: RXRX) announced its second-quarter 2026 financial results, highlighted by Genentech advancing the first neuroscience target from their collaboration into an early discovery program. This milestone validates Recursion's AI-native platform for identifying novel biological targets. The company also provided updates on its pipeline, …

VGNT SEC Filings - Versigent PLC 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for Versigent PLC (VGNT) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. Each filing is enhanced with AI-generated summaries, sentiment and impact scores from Rhea-AI, and end-of-day stock performance data. The platform aims to simplify …

Versigent (NYSE: VGNT) lifts 2026 sales outlook, declares dividend

Versigent PLC reported strong Q2 2026 results, with net sales up 10.8% to $2,444 million and Adjusted EBITDA increasing by 24.8% to $272 million. The company raised and narrowed its full-year 2026 net sales guidance to $9,400-$9,600 million and declared an inaugural quarterly cash …

Recursion Pharmaceuticals en la atención mientras los resultados ponen a prueba su promesa de IA

Diversified Energy (DEC) Earnings Date and Reports 2026 $DEC

DEC|Diversified Energy Company PLC|Price:14.340|Chg%:+0.490

Diversified Healthcare Trust (DHC) Stock Faces Debt Question After Margin Rebound

Diversified Royalty Corp. Announces August 2026 Cash Dividend and Q2 2026 Earnings Release Date

How Rush Street Interactive Inc. Class A (RSI) Affects Rotational Strategy Timing

This article analyzes Rush Street Interactive Inc. Class A (RSI) providing key findings for traders. It highlights weak near and mid-term sentiment but a strong long-term outlook, with an exceptional risk-reward setup. The piece outlines three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk …

Versigent PLC (VGNT) (Q2 2026) Earnings Call Highlights: Record Launches and Dividend ... By GuruFocus

Versigent PLC reported strong Q2 2026 results with an 11% increase in net sales to $2.4 billion and a 25% rise in adjusted EBITDA. The company achieved record launch activity, secured $2.8 billion in new awards, and initiated its first quarterly dividend of $0.13 …

Diversified Healthcare Trust Encounters Operational ‘Noise’ in Ongoing Portfolio Transitions

Diversified Healthcare Trust (DHC) reported lower-than-expected occupancy and revenue in Q2 2026, which CEO Chris Bilotto attributed to "transition noise" from switching operators for 116 communities. Despite this, the company saw sequential occupancy gains and increased NOI margins, reaffirming its SHOP NOI guidance for …

BMNR Stock Tracks Ethereum Surge As Staking And Buybacks Ramp

BitMine Immersion Technologies (BMNR) stock has seen a 3.97% surge, primarily driven by its significant Ethereum holdings and staking activities through its MAVAN platform. The company controls about 4.8% of the total ETH supply, generating substantial annualized staking revenues, and is undertaking a $4B …

Diversified Healthcare Trust Q2 Profit Jumps 20% on Senior Housing Strength, Leverage Drops

Diversified Healthcare Trust (DHC) reported strong Q2 results, with consolidated NOI up 20.4% year over year, driven by a significant jump in senior housing operating portfolio (SHOP) NOI and improved occupancy and rates. The company reaffirmed its 2026 guidance for adjusted EBITDARE and normalized …

Earnings call transcript: Diversified Healthcare Trust posts Q2 2026 miss but lifts outlook

Diversified Healthcare Trust (DHC) reported a Q2 2026 loss of $0.16 per share on revenue of $365.39 million, missing analyst expectations. Despite the miss, the company reaffirmed its full-year guidance, driven by strong operating trends, particularly in its senior housing operating properties (SHOP) segment, …

Persimmon Plc Revenue Breakdown – LSE:PSN